Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Arthritis Rheumatol. 2020 Mar 5;72(4):667–676. doi: 10.1002/art.41165

Figure 3. Clinical characteristics of subsets of giant cell arteritis in the restricted cohort.

Figure 3.

Differences are shown in the prevalence of (A) ischemic cranial symptoms, (B) vascular abnormalities, (C) constitutional symptoms, and (D) musculoskeletal symptoms for each giant cell arteritis subset. TA(−)/LV(−): patients without evidence of temporal artery or large-vessel involvement; TA(+)/LV(−): patients with evidence of temporal artery involvement without evidence of large-vessel involvement; TA(−)/LV(+): patients with evidence of large-vessel involvement without evidence of temporal artery involvement; TA(+)/LV(+): patients with evidence of both temporal artery and large-vessel involvement.